Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Is an Onslaught of Pain on the Horizon?

Vanessa Caceres  |  Issue: February 2011  |  February 12, 2011

New Approaches to Inflammatory Myopathy

ATLANTA— Get ready for more reports of chronic pain from your patients.

That’s the message conveyed by Carmen R. Green, MD, professor of anesthesiology, obstetrics, and gynecology, and health management and policy at the University of Michigan in Ann Arbor, at the 2010 ACR/ARHP Annual Scientific Meeting. [Editor’s Note: This session was recorded and is available via ACR SessionSelect at www.rheumatology.org.]

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Green and David A. Williams, MD, professor of anesthesiology, medicine, psychiatry, and radiology at the University of Michigan, addressed socioeconomic, racial, and other disparities as they relate to the treatment of pain and healthcare in general.

Rheumatologists—and physicians in general—will treat chronic pain more often in the coming years due to both an aging and increasingly diverse population, Dr. Green said, because chronic pain seems to be more common in older and minority patients. “Baby boomers are not going to walk around living with their pain,” she said.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Green shared statistics regarding life expectancy (an average of 80 years for white women and 74.9 years for black women, and 74.8 years and 68.2 years for white and black men, respectively) but pointed out that the differences in the life expectancy of blacks versus whites can relate to the healthcare they receive.

Another factor in the pain treatment environment is the large difference between the way that patients of different races and genders receive pain treatment, as demonstrated by historical data, medical research, and patient anecdotes, she said.

Dr. Green also cited the results of a landmark study on racial disparities in healthcare called “The effect of race and sex on physicians’ recommendations for cardiac catheterization,” published in the New England Journal of Medicine.1 The study had actors in video interviews who portrayed patients with certain symptoms. More than 700 physicians viewed the interviews and received other data about the “patients.” Researchers assessed the effects of the race and sex of patients on the physicians’ treatment recommendations and controlled for physicians’ assessment of coronary artery disease possibility, patient age, level of coronary risk, and chest pain type. The study found that physicians gave a lower estimate of probability of coronary disease for women, younger patients, and patients with nonanginal pain. They also found that women and blacks were less likely to be referred for cardiac catheterization compared with men and whites. Black women were significantly less likely to be referred for catheterization compared with white men, according to the study.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsPain SyndromesSoft Tissue Pain Tagged with:2010 ACR/ARHP Annual Scientific MeetingFibromyalgiaPainpatient carerheumatologist

Related Articles

    Revising Fibromyalgia: One Year Later

    July 12, 2011

    The 2010 ACR fibromyalgia criteria capture the broader clinical picture and help ensure more appropriate diagnosis and management by primary care

    Is Fibromyalgia Overdiagnosed?

    October 10, 2016

    Are too many patients diagnosed with fibromyalgia? The co-authors of one new study believe that close to 75% of patients who have received a clinical fibromyalgia diagnosis do not meet the 2010 Preliminary American College of Rheumatology (ACR) Criteria for Fibromyalgia.1 They say these patients are false-positive and may be taking treatments they don’t need….

    Diagnosing & Caring for Patients with Fibromyalgia

    May 19, 2022

    Doebl et al. compared the effect of symptoms and the healthcare use of people with fibromyalgia with those who fulfilled the criteria for fibromyalgia but had not been diagnosed and those with chronic pain. They found patients diagnosed with fibromyalgia reported the poorest healthcare experiences and were more likely than other study participants to be unemployed due to health issues. Their findings reveal an urgent need exists for a model of care for patients with fibromyalgia.

    Treat-to-Target Strategy Evaluated for Fibromyalgia Care

    September 19, 2017

    Treat-to-target is a widely used approach for rheumatoid arthritis, in which rheumatologists prescribe treatments to reach established benchmarks of disease activity.1 Is it time for a similar approach for fibro­myalgia treatment, even though its pathogenesis, disease-activity measures and treatment algorithms are less well understood? Three fibromyalgia researchers present their case in a new paper, “Treat-to-Target…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences